Jane Street’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.9M | Sell |
60,600
-24,200
| -29% | -$4.7M | ﹤0.01% | 2325 |
|
|
2025
Q4 | $14.7M | Buy |
84,800
+100
| +0.1% | +$18.2K | ﹤0.01% | 1887 |
|
|
2025
Q3 | $16.1M | Buy |
84,700
+12,000
| +17% | +$2.13M | ﹤0.01% | 1866 |
|
|
2025
Q2 | $13.1M | Sell |
72,700
-30,100
| -29% | -$5.23M | ﹤0.01% | 1851 |
|
|
2025
Q1 | $17.4M | Buy |
102,800
+86,600
| +535% | +$14.2M | ﹤0.01% | 1413 |
|
|
2024
Q4 | $2.44M | Sell |
16,200
-1,600
| -9% | -$249K | ﹤0.01% | 3761 |
|
|
2024
Q3 | $2.76M | Sell |
17,800
-10,400
| -37% | -$1.55M | ﹤0.01% | 3880 |
|
|
2024
Q2 | $3.86M | Sell |
28,200
-7,000
| -20% | -$959K | ﹤0.01% | 3379 |
|
|
2024
Q1 | $4.69M | Buy |
35,200
+13,800
| +64% | +$1.79M | ﹤0.01% | 2706 |
|
|
2023
Q4 | $2.95M | Sell |
21,400
-11,300
| -35% | -$1.49M | ﹤0.01% | 3664 |
|
|
2023
Q3 | $3.98M | Sell |
32,700
-1,900
| -5% | -$253K | ﹤0.01% | 2937 |
|
|
2023
Q2 | $4.86M | Buy |
34,600
+16,500
| +91% | +$2.27M | ﹤0.01% | 2776 |
|
|
2023
Q1 | $2.56M | Sell |
18,100
-38,500
| -68% | -$5.51M | ﹤0.01% | 3413 |
|
|
2022
Q4 | $8.85M | Buy |
56,600
+600
| +1% | +$86.2K | ﹤0.01% | 1758 |
|
|
2022
Q3 | $6.87M | Sell |
56,000
-12,600
| -18% | -$1.66M | ﹤0.01% | 2155 |
|
|
2022
Q2 | $9.12M | Sell |
68,600
-36,400
| -35% | -$4.96M | ﹤0.01% | 1854 |
|
|
2022
Q1 | $14.4M | Sell |
105,000
-23,400
| -18% | -$3.26M | ﹤0.01% | 1581 |
|
|
2021
Q4 | $22.2M | Buy |
128,400
+32,900
| +34% | +$5.01M | 0.01% | 1125 |
|
|
2021
Q3 | $13.9M | Buy |
95,500
+80,700
| +545% | +$11.8M | ﹤0.01% | 1427 |
|
|
2021
Q2 | $1.95M | Sell |
14,800
-20,700
| -58% | -$2.71M | ﹤0.01% | 4377 |
|
|
2021
Q1 | $4.56M | Sell |
35,500
-75,400
| -68% | -$9.29M | ﹤0.01% | 2541 |
|
|
2020
Q4 | $13.2M | Buy |
110,900
+54,400
| +96% | +$6.63M | 0.01% | 1188 |
|
|
2020
Q3 | $6.47M | Buy |
56,500
+7,900
| +16% | +$933K | ﹤0.01% | 1596 |
|
|
2020
Q2 | $5.54M | Sell |
48,600
-1,400
| -3% | -$148K | ﹤0.01% | 1736 |
|
|
2020
Q1 | $4.01M | Buy |
50,000
+46,600
| +1,371% | +$4.82M | ﹤0.01% | 1358 |
|
|
2019
Q4 | $363K | Buy |
+3,400
| New | +$355K | ﹤0.01% | 4063 |
|
|
2019
Q3 | – | Sell |
-26,300
| Closed | -$2.68M | – | 5179 |
|
|
2019
Q2 | $2.68M | Sell |
26,300
-22,500
| -46% | -$2.16M | ﹤0.01% | 1588 |
|
|
2019
Q1 | $4.39M | Buy |
48,800
+41,200
| +542% | +$3.57M | 0.01% | 1254 |
|
|
2018
Q4 | $633K | Buy |
+7,600
| New | +$713K | ﹤0.01% | 3168 |
|
|
2018
Q2 | – | Sell |
-6,200
| Closed | -$622K | – | 5053 |
|
|
2018
Q1 | $622K | Buy |
+6,200
| New | +$635K | ﹤0.01% | 3226 |
|
|
2017
Q4 | – | Sell |
-18,600
| Closed | -$1.74M | – | 4658 |
|
|
2017
Q3 | $1.74M | Buy |
+18,600
| New | +$1.97M | 0.01% | 1729 |
|
|
2017
Q2 | – | Sell |
-17,500
| Closed | -$1.72M | – | 4410 |
|
|
2017
Q1 | $1.72M | Buy |
+17,500
| New | +$1.67M | 0.01% | 1515 |
|
|
2016
Q1 | – | Sell |
-3,800
| Closed | -$270K | – | 4137 |
|
|
2015
Q4 | $270K | Buy |
+3,800
| New | +$255K | ﹤0.01% | 3224 |
|
|
2015
Q3 | – | Sell |
-4,200
| Closed | -$305K | – | 3670 |
|
|
2015
Q2 | $305K | Buy |
+4,200
| New | +$310K | ﹤0.01% | 2807 |
|
Other funds holding DGX
VCM
VPM
EIG
Jane Street's DGX Position: Q1 2026 in Review
Jane Street reduced its Quest Diagnostics (DGX) stake by 98% in Q1 2026, selling an estimated $55.6M and leaving 6,429 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #6017.
Jane Street first reported a position in DGX in Q3 2013 and has held it in 39 quarters since. The position peaked at $50.8M in Q4 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Jane Street held 6,429 shares of Quest Diagnostics worth $1.26M as of Q1 2026.
- Jane Street sold 286,305 Quest Diagnostics shares in Q1 2026, an estimated $55.6M.
- Quest Diagnostics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6017 holding.
- Jane Street first reported a position in Quest Diagnostics in Q3 2013 and has held it in 39 quarters since.
- Jane Street's Quest Diagnostics position peaked at $50.8M in Q4 2025.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.